APAIIF 亞太人工智能產業總會APAIIFAI Knowledge

AI in Healthcare

Discover AI applications and innovations in healthcare

65 articles

Midjourney Medical Launches Full-Body Ultrasound Scanner: 60-Second 3D Body Maps, Targeting 50,000 Deployments by 2031, Pending FDA Clearance

Midjourney Medical Launches Full-Body Ultrasound Scanner: 60-Second 3D Body Maps, Targeting 50,000 Deployments by 2031, Pending FDA Clearance

Midjourney Medical launched a full-body ultrasound scanner prototype in June 2026 that generates 3D body maps in 60 seconds using $74M licensed Ultrasound-on-Chip technology, targeting 50,000 global deployments by 2031, but currently lacks FDA diagnostic clearance and is initially positioned as a body composition mapping service.

Aug 29, 202611
GRAIL Galleri Multi-Cancer Early Blood Test: FDA Advisory Committee Review Set for September 23, Backed by 70,000-Person Clinical Trial Data

GRAIL Galleri Multi-Cancer Early Blood Test: FDA Advisory Committee Review Set for September 23, Backed by 70,000-Person Clinical Trial Data

The U.S. FDA announced an advisory committee meeting for September 23, 2026, to review GRAIL's Galleri multi-cancer early detection blood test PMA application. Galleri uses AI to analyze DNA methylation patterns in blood, detecting over 50 cancer types simultaneously, backed by a 70,000-person NHS randomized controlled trial.

Aug 28, 202611
AI Healthcare Diagnosis Breakthrough: Harvard Study, FDA-Approved 1250+ Devices, and Asia-Pacific Hospital Adoption

AI Healthcare Diagnosis Breakthrough: Harvard Study, FDA-Approved 1250+ Devices, and Asia-Pacific Hospital Adoption

In healthcare AI, winning is not about benchmark scores. It is about workflow integration, governance, and measurable ROI in real hospitals.

Aug 18, 202623
AI Medical Diagnosis in 2026: Accuracy, Regulation, and Asia-Pacific Adoption

AI Medical Diagnosis in 2026: Accuracy, Regulation, and Asia-Pacific Adoption

In 2026, AI diagnosis is not won by the best model score, but by workflow fit, accountability, and regulatory scalability across APAC.

May 2, 202619
The AI Drug Discovery Revolution: Shortening R&D Timelines and Cutting Costs

The AI Drug Discovery Revolution: Shortening R&D Timelines and Cutting Costs

AI drug discovery is not mainly about replacing scientists. It is about killing weak programs earlier, testing fewer bad molecules, and improving capital efficiency.

Apr 10, 202618
PreviousPage 6 / 6